CTRI/2026/03/105819尚未招募不适用
Effectiveness of ISBAR handover protocol training on clinical acumen among nurse at interns at selected colleges of himachal pradesh
Ms Maga Pira2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年3月20日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
- 试验地点
- 2
- 主要终点
- nurse interns will have adequate knowledge regarding ISBAR handover
研究概览
简要总结
Phase I:
- On the first day, consent will be taken from the Principal of selected colleges of Himachal Pradesh
- A purposive sampling technique will be used to choose the sample.
- Data collection began with a pre-test utilising a structured questionnaire and a vignette based question for both the control and experimental groups to assess participants existing knowledge and decision making skills regarding ISBAR handover. Knowledge will be evaluated using a structured questionnaire, while decision making will be measured using a vignette based assessment tool consisting of written case scenarios. On the second day, theoretical training regarding ISBAR handover protocol will be delivered through a lecture only to the experimental group to allow the learners to gain knowledge and critical handover skills of ISBAR principle.
Phase II
- On the 3rd day, post-test will be conducted for both the control and experimental group using the same structured questionnaire and vignette-based assessment tool.
研究设计
- 研究类型
- Interventional
- 分配方式
- Coin toss, Lottery, toss of dice, shuffling cards etc
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 20.00 Year(s) 至 25.00 Year(s)(—)
- 性别
- All
入选标准
- •1.Nurse interns who will be available at the time of data collection and willing to participate in the study 2.Both genders.
排除标准
- •Those who will have a hand injury and won’t be able to write.
结局指标
主要结局
nurse interns will have adequate knowledge regarding ISBAR handover
时间窗: 1 years
次要结局
未报告次要终点
研究者
Ms Maga Pira
Akal College of Nursing Baru Sahib
研究点 (2)
Loading locations...
相似试验
招募中
2 期
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to EfgartigimodMGGeneralized Myasthenia GravisgMGMyasthenia GravisNCT07284420argenx70
招募中
2 期
A trial to learn how safe saruparib is and how well it works in people with advanced ovarian cancer2024-519044-32-00AstraZeneca AB16
招募中
2 期
CO43923 Master Protocol: A Study Evaluating the Safety and Efficacy of Multiple Treatments in Patients with Multiple Myeloma CO43923 Substudy 1: A Study to Collect Patient-Level Data in Patients with Multiple Myeloma CO43923 Substudy 2 Cevos + Len Treatment: A Study Evaluating the Safety and Efficacy of Cevostamab in Combination with Lenalidomide in Patients with Cytogenetic High-Risk Features Receiving Maintenance Treatment After First Response from Multiple Myeloma Post-Stem Cell Transplant CO43923 Substudy 4 Cevostamab+ Iberdomide Treatment: A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Cevostamab in Combination with Iberdomide in Patients with Relapsed or Refractory Multiple Myeloma2023-504484-16-00F. Hoffmann-La Roche AG32
尚未招募
不适用
A Study on How Moving Patients Early During Serious Illness, Compared to Regular ICU Care, Helps Them Recover Strength and Function, and Prevents Muscle Loss.CTRI/2025/10/096710Abhijith S60
尚未招募
不适用
Study to assess the effectiveness of standardized hands-on-training regarding Tracheostomy Care on Knowledge and Skills of Caregivers of Tracheostomized PatientsCTRI/2024/09/073374Deepika Choudhary82
